Ubs Group Ag Nrx Pharmaceuticals Inc Wt Exp Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Nrx Pharmaceuticals Inc Wt Exp stock. As of the latest transaction made, Ubs Group Ag holds 69 shares of NRXPW stock, worth $5. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

% of portfolio

0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.1 - $0.2 $6 - $13	69 New	69 $0
Q3 2023 Nov 09, 2023	BUY	$0.08 - $0.25 $624 - $1,953	7,812 New	7,812 $0
Q1 2023 May 12, 2023	BUY	$0.18 - $0.44 $604 - $1,476	3,356 New	3,356 $0
Q2 2022 Aug 10, 2022	BUY	N/A	186 New	186 $0
Q1 2022 May 16, 2022	SELL	N/A	-4,358 Closed	0 $0

Q4 2021 Feb 14, 2022	BUY	N/A	1,985 Added 83.65%	4,358 $8,000
Q3 2021 Nov 15, 2021	BUY	N/A	2,373 New	2,373 $11,000

Others Institutions Holding NRXPW

# of Institutions

Shares Held

15.7K

Call Options Held

Put Options Held

Susquehanna International Group, LLP Bala Cynwyd, PA

13.4K
Shares

$1,074
0.0% of portfolio
Wolverine Asset Management LLC

2.16K
Shares

$172
0.0% of portfolio
Tower Research Capital LLC (Trc) New York, NY

15
Shares

$1
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About NRX PHARMACEUTICALS INC WT EXP

Ticker NRXPW
Sector Healthcare
Industry Biotechnology

More about NRXPW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account